Current status of lung transplantation

Lau C.L., Patterson G.A.

Source: Eur Respir J 2003; 22: 57S-64S
Journal Issue: November 2003 - Suppl. 47

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lau C.L., Patterson G.A.. Current status of lung transplantation. Eur Respir J 2003; 22: 57S-64S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010



The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Post-transplant bronchiolitis obliterans
Source: Eur Respir J 2003 Dec 01;22(6):1007-1018
Year: 2003



A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008



Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004



Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients?
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

Is lung transplantation still indicated?
Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema
Year: 2006


Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004

The use of surfactant in severe reperfusion injury after lung transplantation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005


Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011


Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?
Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Year: 2006


Post-transplant bronchiolitis obliterans
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158
Year: 2003

Introduction: new therapeutic approaches to bronchiolitis obliterans
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005

Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004

Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004

Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011